# Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer

> **NCT06168552** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Zhejiang University** · enrollment: 20 (estimated)

## Conditions studied

- Resectable Pancreatic Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Injection of fluorescent developer (anti-EGFR-IR800CW)

## Key facts

- **NCT ID:** NCT06168552
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-15
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06168552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06168552, "Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06168552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*